Search Results for "DCIS"
Modest improvement after major treatment touted as ‘reduced risk of dying’ in women with low-threat DCIS
A quarter of a percent reduced risk over a 15-year period seems speculative, not definitive.
Association of radiation therapy plus lumpectomy in reduced risk of dying in women with DCIS
Podcast: DCIS … searching for clarity
What is DCIS, or ductal carcinoma in situ? Is it an incidental abnormality that only became recognized as screening mammography became more widespread and sophisticated?
Or, is it a pre-cancer that gives doctors a head start in treating breast cancer before it spreads?
These are questions that nearly 60-thousand women are faced with each year in this country.
‘Promising results’ from breast cancer vaccine trial — but most patients had noninvasive ductal carcinoma in situ (DCIS)
The release states: “vaccines are more effective in DCIS” but there’s broad disagreement whether these low-grade, noninvasive conditions are cancer.
Vaccine shows promising results for early-stage breast cancer patients
Podcast: DCIS dilemma – Dr. Laura Esserman
Dr. Laura Esserman is a surgeon and breast cancer specialist who works at the University of California San Francisco. The San Francisco Chronicle last year called her a rock star. She told the newspaper that she is driven by “Passion, persistence and energy. I want to drive efforts to completion: change the way we run clinical trials.”6
New DCIS study, news release lead to (very) mixed messages: ‘And we wonder why patients get confused’
The following is the first contribution to the blog by Dave Mosher, a deputy editor at Tech Insider who joined the HealthNewsReview.org team of reviewers earlier this year. His writing about science, technology, and innovation has appeared in outlets such as WIRED, Popular Science, and Scientific American. It’s an all-too-common theme in the theater of health news: scientists publish […]
A “practice-changing” test for DCIS — but does it impact results that matter to patients?
This release focused on how the results of a test changed doctors’ treatment recommendations. It didn’t address whether those revised recommendations would improve outcomes for patients.
Journal of Surgical Oncology Publishes Study Showing Oncotype DX® DCIS Score™ Result Changes Treatment Recommendations in 30 Percent of DCIS Breast Cancer Patients Physicians Ranked Oncotype DX DCIS Score Most Important Factor in Treatment Planning
Why did last week’s mammography study get so much news, but the DCIS study didn’t?
Last week, journalists were handed a wonderful opportunity to educate readers about one important part of the dilemma in breast cancer screening recommendations. Most of them blew the chance. Two unrelated papers were published in two different journals. But while the work behind the papers was unrelated – different research teams with a different […]1/23/2014
A patient advocate’s powerful piece on Lisa Bonchek Adams and the Kellers’ criticism – the DCIS Sea of Uncertainty
I’ve been slow to comment on the firestorm of criticism that arose when Emma Keller of The Guardian questioned the Twitter messages by Lisa Bonchek Adams, a young woman with stage IV breast cancer. I haven’t felt the need to comment since so many people have done such a thorough job of writing about this […]7/21/2010
Excellent story by New York Times on DCIS
I’ve spoken and written about the imbalance in the news coverage about the U.S. Preventive Service Task Force’s new guidelines on mammography last November. If stories and communications are going to use anecdotes, then for every anecdote about a woman who claims her life was saved by a mammogram in her 40s (something that can’t […]1/14/2010
Why don't journalists pay more attention to DCIS?
The LA Times Booster Shots Blog was one of the handful of news organizations that wrote anything about the Journal of the National Cancer Institute articles this week on DCIS or ductal carcinoma in situ. The Times wrote: “The issue is important because 25% of all breast cancers diagnosed in the United States are DCIS. […]
Breast center marketing pitch via reporter’s live-streamed mammogram was a bad idea
Breast Cancer Awareness Month is over for another year. But it’s not too late to reflect on, and learn from, one of the most troublesome breast center marketing ideas in recent memory. As described in stories all over the globe, including in the Washington Post, the NBC Today Show website, People magazine, Adweek, and Fox News, a […]
Better to sacrifice brevity in favor of clarity when promoting breast cancer screening strategies
This news release makes recommendations on a very important topic — when lymph node biopsies may not be necessary in breast cancer diagnosis — and deserved more details.
Allina study shows patients with very small breast tumors may forgo lymph node biopsies
Podcast: The top 10 quotes of 2017
In this podcast — our 13th of the year (and 38th episode since we started producing them in the summer of 2015) — we take a look back at some memorable conversations from the past year.
We spoke with quite a mix of inspirational individuals, covered a wide range of fascinating topics, and thought we’d share with you what we considered to be some of the most compelling quotes.
So here you go … The Top 10 Quotes of 2017
Recap of abbreviated breast MRI study veers into disease mongering
Having dense breasts may make screening more challenging, but it shouldn’t be used to add to women’s fears about their breast cancer risk.
Abbreviated breast MRI may be additional screening option for dense breasts
Breast Cancer Awareness Month: How do we end up pink-washed every October?
The White House and Empire State Building are being lit pink this week. Model Elizabeth Hurley recently passed out pink ribbons on a transatlantic flight. Firefighters, football players, and even people’s dogs are donning the pink … … all in support of Breast Cancer Awareness Month which kicked off this past weekend. It’s been going […]